OncoIndx is a first-in-class comprehensive genomic profiling solution developed by OneCell Diagnostics. It leverages next-generation sequencing (NGS) to analyze over 1,000 cancer-relevant genes, including rare mutations and treatment resistance markers. Enhanced with AI/ML capabilities, OncoIndx delivers precision insights that help oncologists tailor treatments to each patient’s unique cancer profile.
Designed for use with both tissue and liquid biopsy samples, OncoIndx provides deep coverage (up to 5,000x for blood samples) to ensure accurate detection of ctDNA. It supports a wide range of clinical applications—from assessing tumor mutational burden and microsatellite instability to predicting chemotherapy toxicity and matching patients to immunotherapy or targeted therapies.
At the core of OncoIndx is the iCARE platform—a secure, interactive reporting system built by oncologists for oncologists. It enables real-time variant visualization, collaborative decision-making, and access to curated reference data. Whether for newly diagnosed patients or those facing treatment resistance, OncoIndx offers a smarter path forward in personalized cancer care.